| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2024 | LFWD Lifeward Ltd. | Jasinski Lawrence J62 | Chief Executive Officer | Sell | 3,466 | $4.22 | $14,617.16 | -3.2% | -24.5% | -74.6% | |
| Jun 18, 2024 | DXCM Dexcom Inc | Foletta Mark G72 | Director | Sell | 6,000 | $117.00 | $702,028.84 | -2.0% | -39.9% | -30.5% | |
| Jun 17, 2024 | OWLT Owlet, Inc. | Scolnick Kathryn R.69 | Chief Financial Officer | Sell | 197 | $4.56 | $898.32 | -0.2% | -4.6% | +50.2% | |
| Jun 17, 2024 | CATX Perspective Therapeutics, Inc. | Hunt Jonathan Robert61 | Chief Financial Officer | Buy | 1,800 | $9.82 | $17,667.00 | +5.3% | +26.9% | -65.9% | |
| Jun 17, 2024 | BVS Bioventus Inc. | Church Katrina J52 | SVP &Chief Compliance Officer | Sell | 8,759 | $5.84 | $51,152.56 | -19.9% | +86.2% | +6.9% | |
| Jun 17, 2024 | BVS Bioventus Inc. | Singleton Mark Leonard46 | SVP &CFO | Sell | 13,753 | $5.84 | $80,317.52 | -17.9% | +86.2% | +6.9% | |
| Jun 17, 2024 | PRCT Procept Biorobotics Corp | Nouri Alaleh50 | EVP, CLO, Corp. Sec. | Sell | 10,000 | $62.18 | $621,763.93 | -8.6% | +32.2% | -4.9% | |
| Jun 17, 2024 | OWLT Owlet, Inc. | Workman Kurt55 | Chief Executive Officer | Sell | 761 | $4.56 | $3,470.16 | -0.4% | -4.6% | +50.2% | |
| Jun 17, 2024 | BVS Bioventus Inc. | D'adamio Anthony61 | SVP &General Counsel | Sell | 11,308 | $5.84 | $66,038.72 | -12.2% | +86.2% | +6.9% | |
| Jun 17, 2024 | SSII Ss Innovations International, Inc. | Cohen Barry F | COO - Americas | Buy | 575 | $4.06 | $2,336.00 | - | - | - | |
| Jun 14, 2024 | RXST Rxsight, Inc. | Andrews Julie55 | Director | Sell | 15,625 | $58.00 | $906,288.14 | -19.6% | -5.8% | -75.5% | |
| Jun 14, 2024 | RGEN Repligen Corp | Hunt Anthony75 | Chief Executive Officer | Buy | 2,000 | $124.08 | $248,160.00 | +1.2% | +13.0% | +1.5% | |
| Jun 14, 2024 | DXCM Dexcom Inc | Heller Bridgette P62 | Director | Sell | 1,000 | $113.55 | $113,550.00 | -3.8% | -40.6% | -29.3% | |
| Jun 14, 2024 | WRBY Warby Parker Inc. | D1 Capital Partners L.P.53 | 10% Owner | Sell | 5,500,000 | $15.66 | $86,130,000.00 | -36.8% | -11.4% | +36.1% | |
| Jun 14, 2024 | TMDX Transmedics Group, Inc. | Hassanein Waleed H56 | President &CEO | Sell | 8,625 | $141.85 | $1,223,473.20 | -2.6% | +5.0% | +0.6% | |
| Jun 14, 2024 | RGEN Repligen Corp | Barthelemy Nicolas67 | Director | Buy | 1,200 | $125.45 | $150,540.00 | +34.6% | +13.0% | +1.5% | |
| Jun 14, 2024 | CNMD Conmed Corp | Peters Stanley W III79 | President As And Aet | Sell | 4,000 | $71.82 | $287,280.00 | -98.4% | +8.2% | -24.7% | |
| Jun 14, 2024 | CATX Perspective Therapeutics, Inc. | Woods Lori A70 | Director | Buy | 4,587 | $10.90 | $49,990.00 | +1.5% | +48.0% | -70.4% | |
| Jun 14, 2024 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 10,000 | $20.18 | $201,800.00 | -8.4% | +20.2% | +9.1% | |
| Jun 14, 2024 | PODD Insulet Corp | Field Mark N | SVP &Chief Technology Officer | Sell | 1,500 | $199.96 | $299,940.00 | -10.4% | +15.0% | +52.0% | |
| Jun 14, 2024 | RGEN Repligen Corp | Madaus Martin D72 | Director | Buy | 1,615 | $124.94 | $201,776.10 | +23.4% | +13.0% | +1.5% | |
| Jun 14, 2024 | STXS Stereotaxis, Inc. | Isaac Paul J78 | Director, See Remarks | Buy | 7,000 | $1.86 | $13,017.20 | +0.3% | +18.3% | +13.4% | |
| Jun 13, 2024 | WRBY Warby Parker Inc. | Briggs Teresa63 | Director | Sell | 7,396 | $16.31 | $120,628.76 | -16.0% | -13.0% | +36.7% | |
| Jun 13, 2024 | HBIO Harvard Bioscience Inc | Green James W70 | Chief Executive Officer | Buy | 10,000 | $2.91 | $29,100.00 | +0.3% | -2.7% | -82.5% | |
| Jun 13, 2024 | ECOR Electrocore, Inc. | Gandolfo John P | Director | Buy | 1,000 | $6.43 | $6,430.00 | +2.0% | -5.4% | -19.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.